Transcatheter Heart Valve Replacement Devices Market to Reach US$ 29.05 Billion by 2031, Driven by Aging Population, Minimally Invasive Procedures, and Expanding Indications

According to DataM Intelligence, the global transcatheter heart valve replacement devices market was valued at approximately US$ 13.34 billion in 2024 and is expected to reach around US$ 29.05 billion by 2031, growing at a CAGR of 11.65% during the forecast period 2024-2031. Growth is propelled by the rising prevalence of valvular heart diseases, increasing preference for minimally invasive transcatheter procedures over open-heart surgery, expanding approvals for new indications, technological advancements in valve designs, and growing adoption in emerging markets.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/transcatheter-heart-valve-replacement-devices-market?jd

North America Key Industry Developments
✅ January 2026: Abbott announced positive outcomes from real-world studies of its Navitor transcatheter aortic valve system, enhancing its position in severe aortic stenosis treatment.
✅ December 2025: Edwards Lifesciences Corporation received expanded FDA approval for its SAPIEN 3 Ultra Resilia valve in additional low-risk patient populations, boosting transcatheter aortic valve replacement (TAVR) adoption.
✅ December 2025: Medtronic plc. reported strong clinical data from ongoing trials of its Evolut PRO+ self-expandable system, with increased market share in TAVR procedures across major U.S. centers.

Asia-Pacific Key Industry Developments
✅ January 2026: Meril Life Sciences and Sahajanand Medical Technologies Limited strengthened distribution networks in India and other APAC countries, capitalizing on rising demand for cost-effective TAVR solutions.
✅ December 2025: Venus Medtech (Hangzhou) Inc. expanded commercial access to its VenusA-Valve system in China and Southeast Asia, with new regulatory clearances for broader indications.
✅ December 2025: Peijia Medical Limited and MicroPort Scientific Corporation accelerated domestic production and clinical partnerships for next-generation transcatheter valves targeting mitral and pulmonary applications.

Key Mergers and Acquisitions
✅ Strategic Collaboration: Major players like Boston Scientific Corporation and JenaValve Technology pursued licensing and co-development agreements for advanced mechanically expandable valves.
✅ Regional Expansion: Asian manufacturers deepened partnerships with global firms to accelerate technology transfer and local manufacturing for transcatheter devices.

Purchase this report before year end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=transcatheter-heart-valve-replacement-devices-market
(Purchase 2 or more Reports and get 50% Discount)

Market Segmentation Analysis
-By Product: Self-Expandable Transcatheter Aortic Valves lead due to ease of deployment and clinical outcomes; followed by Balloon Expandable and Mechanically Expandable Transcatheter Aortic Valves.
-By Procedure Type: Transcatheter Aortic Valve Replacement (TAVR) dominates the market, with growing segments in Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Pulmonary Valve Replacement (TPVR).
-By Indication: Severe Aortic Valve Stenosis accounts for the largest share; Aortic Regurgitation and Others are emerging.
-By End-Users: Hospitals hold the primary share, followed by Ambulatory Surgical Centers and Cardiac Catheterization Laboratories.

Regional Insights
North America commands the largest market share, driven by advanced healthcare infrastructure, high reimbursement rates, early adoption of innovative TAVR technologies, and strong clinical evidence supporting expanded indications. Asia-Pacific is the fastest-growing region, fueled by increasing prevalence of cardiovascular diseases, improving healthcare access, government initiatives for cardiac care, and rapid commercialization of cost-effective devices by local players.

Growth Drivers
1. Rising geriatric population and increasing incidence of valvular heart diseases globally
2. Shift toward minimally invasive procedures with shorter recovery times and lower risks
3. Continuous technological advancements in valve durability, delivery systems, and repositionability
4. Expanding regulatory approvals for new valves and broader patient indications
5. Growing investments, clinical trials, and market penetration by both global and regional manufacturers in the Asia-Pacific

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/transcatheter-heart-valve-replacement-devices-market?jd

Key Players
The market includes leading companies such as Abbott, Edwards Lifesciences Corporation, Medtronic plc., Boston Scientific Corporation, JenaValve Technology, Inc., Meril Life Sciences, Sahajanand Medical Technologies Limited, MicroPort Scientific Corporation, Venus Medtech (Hangzhou) Inc., and Peijia Medical Limited.

Key Highlights (Top 5 Key Players)
1. Edwards Lifesciences Corporation - Market leader in balloon-expandable TAVR with SAPIEN platforms and ongoing expansions into new risk categories.
2. Medtronic plc. - Strong presence in self-expandable TAVR with Evolut series, supported by robust clinical data and global reach.
3. Abbott - Advancing next-generation transcatheter systems with focus on aortic and emerging mitral applications.
4. Venus Medtech (Hangzhou) Inc. - Leading Asian innovator with rapid commercialization of cost-effective TAVR solutions across APAC.
5. Boston Scientific Corporation - Expanding portfolio through innovative valve technologies and strategic partnerships.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd

Power your decisions with real time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape Analysis
✅ Company Profile Analysis
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updates
✅ Live Market & Pricing Trends
✅ Regulatory and Supply Chain Analysis
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.